Potter sequence

From WikiMD's WELLNESSPEDIA

(Redirected from Potter disease, type 3)


Potter sequence
Synonyms Potter syndrome, Oligohydramnios sequence
Pronounce N/A
Specialty N/A
Symptoms Pulmonary hypoplasia, renal agenesis, limb deformities, facial anomalies
Complications Respiratory distress, renal failure
Onset Prenatal
Duration Lifelong
Types N/A
Causes Oligohydramnios, renal agenesis, obstructive uropathy
Risks Genetic factors, maternal conditions
Diagnosis Ultrasound, amniocentesis, genetic testing
Differential diagnosis Meckel-Gruber syndrome, VACTERL association
Prevention Prenatal care, genetic counseling
Treatment Supportive care, neonatal intensive care, renal transplantation
Medication N/A
Prognosis Poor, often fatal
Frequency Rare
Deaths N/A


Potter sequence (also known as Potter's Syndrome or Potter's Sequence) is a rare condition characterized by a lack of amniotic fluid in the womb during pregnancy, leading to fetal complications. It is named after Edith Potter, a pathologist who first described the condition in 1946.

Causes[edit]

Potter sequence is typically caused by bilateral renal agenesis (BRA), a condition in which the kidneys fail to develop in the fetus. Other causes can include chronic placental insufficiency, ruptured membranes, and other conditions that lead to a decrease in amniotic fluid.

Symptoms[edit]

The primary symptom of Potter sequence is oligohydramnios, a condition characterized by a deficiency of amniotic fluid. This can lead to a number of complications for the fetus, including pulmonary hypoplasia (underdeveloped lungs), limb deformities, and characteristic facial features (Potter's facies) such as low-set ears, a broad, flat nose, and a receding chin.

Diagnosis[edit]

Potter sequence is usually diagnosed through prenatal ultrasound, which can detect the absence of kidneys and a lack of amniotic fluid. Postnatal diagnosis can be made based on the characteristic physical features of the baby.

Treatment[edit]

There is currently no cure for Potter sequence. Treatment is supportive and depends on the severity of the condition. This may include interventions to support breathing and kidney function.

Prognosis[edit]

The prognosis for Potter sequence is generally poor, with most babies dying shortly after birth due to respiratory failure. However, some babies with less severe forms of the condition may survive with intensive medical support.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.